1 |
Wei, G., de Leeuw, E., Pazgier, M., Yuan, W., Zou, G., Wang, J., Ericksen, B., Lu, W. Y., Lehrer, R. I., and Lu, W. 2009. Through the looking glass, mechanistic insights from enantiomeric human defensins. J. Biol. Chem. 284, 29180-29192.
DOI
ScienceOn
|
2 |
Wu, Y. and Smas, C. M. 2008. Wdnm1-like, a new adipokine with a role in MMP-2 activation. Am. J. Physiol. Endocrinol. Metab. 295, E205-E215.
DOI
ScienceOn
|
3 |
Zasloff, M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415, 389-395.
DOI
|
4 |
Porcelli, F., Buck, B., Lee, D. K., Hallock, K. J., Ramamoorthy, A. and Veglia, G. 2004. Structure and orientation of pardaxin determined by NMR experiments in model membranes. J. Biol. Chem. 279, 45815-45823.
DOI
|
5 |
Wang, G. 2013. Database-Guided Discovery of Potent Peptides to Combat HIV-1 or Superbugs. Pharmaceuticals 6, 728-758.
DOI
|
6 |
Raimondo, D., Andreotti, G., Saint, N., Amodeo, P., Renzone, G., Sanseverino, M., Zocchi, I., Molle, G., Motta, A. and Scaloni, A. 2005. A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. Proc. Natl. Acad. Sci. USA 102, 6309-6314.
DOI
|
7 |
Rozek, A., Friedrich, C. L. and Hancock, R. E. 2000. Structure of the bovine antimicrobial peptide indolicidin bound to dodecylphosphocholine and sodium dodecyl sulfate micelles. Biochemistry 39, 15765-15774.
DOI
|
8 |
Seo, M. D., Won, H. S., Kim, J. H., Mishig-Ochir, T. and Lee, B. J. 2012. Antimicrobial peptides for therapeutic applications: a review. Molecules 17, 12276-12286.
DOI
|
9 |
Wang, G. 2015. Improved methods for classification, prediction, and design of antimicrobial peptides. Methods Mol. Biol. 1268, 43-66.
DOI
|
10 |
Wang, G. 208. Structures of human host defense cathelicidin LL-37 and its smallest antimicrobial peptide KR-12 in lipid micelles. J. Biol. Chem. 283, 32637-32643.
|
11 |
Wang, G., Li, Y. and Li, X. 2005. Correlation of three-dimensional structures with the antibacterial activity of a group of peptides designed based on a nontoxic bacterial membrane anchor. J. Biol. Chem. 280, 5803-5811.
DOI
|
12 |
Jenssen, H., Hamill, P. and Hancock, R. E. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19, 491-511.
DOI
|
13 |
Karlstetter, M., Walczak, Y., Weigelt, K., Ebert, S., Van den Brulle, J., Schwer, H., Fuchshofer, R. and Langmann, T. 2010. The novel activated microglia/macrophage WAP domain protein, AMWAP, acts as a counter-regulator of proin-flammatory response. J. Immunol. 185, 3379-3390.
DOI
|
14 |
Mekori, Y. A., Hershko, A. Y., Frossi, B., Mion. F., and Pucillo, C. E. 2015. Integrating innate and adaptive immune cells: Mast cells as crossroads between regulatory and effector B and T cells. Eur. J. Pharmacol. pii: S0014-2999(15)00400-004008.
|
15 |
Mookherjee, N. and Hancock, R. E. W. 2007. Cationic host defence peptides: Innate immune regulatory peptides as a novel approach for treating infections. Cell. Mol. Life Sci. 64, 922-933.
DOI
|
16 |
Kolar, S., Baidouri, S., Hanlon, H. and McDermott, A. M. 2013. Protective role of murine β-defensins 3 and 4 and cathelin-related antimicrobial peptide in Fusarium solani keratitis. Infect Immun. 81, 2669-2677.
DOI
ScienceOn
|
17 |
Marr, A. K., Gooderham, W. J. and Hancock, R. E. W. 2006. Antibacterial peptides for therapeutic use: Obstacles and realistic outlook. Curr. Opin. Pharmacol. 6, 468-472.
DOI
|
18 |
Mysliwy, J., Dingley, A. J., Stanisak, M., Jung, S., Lorenzen, I., Roeder, T., Leippe, M. and Grötzinger, J. 2010. Caenopore-5: the three-dimensional structure of an antimicrobial protein from Caenorhabditis elegans. Dev. Comp. Immunol. 34, 323-330.
DOI
|
19 |
Narayana, J. L. and Chen, J. Y. 2015. Antimicrobial peptides: Possible anti-infective agents. Peptides pii: S0196-9781 (15)00168-00170.
|
20 |
Hancock, R. E. W., Brown, K. L. and Mookherjee, N. 2006. Host defence peptides from invertebrates—Emerging antimicrobial strategies. Immunobiology 211, 315-322.
DOI
|
21 |
Bauer, F., Schweimer, K., Klüver, E., Conejo-Garcia, J. R., Forssmann, W. G., Rösch, P., Adermann, K. and Sticht, H. 2001. Structure determination of human and murine beta-defensins reveals structural conservation in the absence of significant sequence similarity. Protein Sci. 12, 2470-2479.
|
22 |
Hancock, R. E. W. 1997. Peptide antibiotics. Lancet 349, 418- 422.
DOI
|
23 |
Brown, K. L. and Hancock, R. E. W. 2006. Cationic host defense (anti-microbial) peptides. Curr. Opin. Immunol. 18, 24-30.
DOI
|
24 |
Conibear, A. C., Rosengren, K. J., Harvey, P. J. and Craik, D. J. 2012. Structural characterization of the cyclic cystine ladder motif of θ-defensins. Biochemistry 48, 9718-9726.
|
25 |
Hancock, R. E. W. 2004. Cationic peptides: Effectors in innate immunity and novel antimicrobials. Lancet Infect. Dis. 1, 156-164.
|
26 |
Huo, T. I. 2010. The first case of multidrug-resistant NDM-1-harboring Enterobacteriaceae in Taiwan: here comes the superbacteria! J. Chin. Med. Assoc. 73, 557-558.
DOI
|